CNMD – conmed corporation (US:NASDAQ)
Stock Stats
News
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.
Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]
Form 8-K CONMED Corp For: Dec 05
Form 4 CONMED Corp For: Nov 21 Filed by: Glaze Richard
Form 4 CONMED Corp For: Nov 20 Filed by: Glaze Richard
Form 144 CONMED Corp Filed by: Glaze Richard
Form SCHEDULE 13G/A CONMED Corp Filed by: Capital Research Global Investors
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.